MICROBIAL PATHOGENESIS
Scope & Guideline
Transforming Understanding into Therapeutic Strategies
Introduction
Aims and Scopes
- Microbial Pathogenesis Mechanisms:
Research exploring the molecular and cellular mechanisms by which pathogens cause disease, including the study of virulence factors and host-pathogen interactions. - Antimicrobial Resistance:
Investigations into the mechanisms of resistance in various microbial species, including bacteria, fungi, and viruses, alongside strategies to combat resistance. - Therapeutic Innovations:
Development and evaluation of new therapeutic strategies, including vaccines, antimicrobial peptides, and phage therapy, aimed at treating infections caused by pathogenic microbes. - Microbiome Research:
Studies focusing on the role of the microbiome in health and disease, particularly how gut and environmental microbiota interact with pathogens and influence disease outcomes. - Zoonotic Diseases:
Research addressing the transmission and pathology of diseases that can be transmitted from animals to humans, emphasizing the importance of understanding these interactions for public health. - Infectious Disease Epidemiology:
Epidemiological studies aimed at understanding the prevalence, risk factors, and transmission dynamics of infectious diseases, particularly in specific populations.
Trending and Emerging
- Environmental Microbiology:
There is an increasing interest in the role of environmental factors and microbiota in disease processes, particularly in the context of climate change and its impact on microbial behavior. - Host-Microbiome Interactions:
Research focusing on the intricate relationships between the host's immune system and its microbiota is gaining traction, showcasing how these interactions can influence disease outcomes. - Vaccine Development:
A notable trend is the focus on innovative vaccine strategies, including multi-epitope vaccines and the use of adjuvants, reflecting the urgent need for effective vaccines against emerging infectious diseases. - Nanotechnology in Microbial Control:
The application of nanotechnology for developing new antimicrobial agents and delivery systems is on the rise, providing novel ways to combat drug-resistant pathogens. - Immunotherapy:
Emerging studies are exploring the potential of immunotherapies, including the use of monoclonal antibodies and immune modulators, in treating infectious diseases and their complications.
Declining or Waning
- Traditional Antibiotics:
There has been a noticeable decline in studies solely focused on conventional antibiotics, as researchers shift towards exploring alternative therapies like phage therapy and antimicrobial peptides. - Single Pathogen Studies:
Research focusing exclusively on individual pathogens without considering their interactions within the microbiome or with host systems is waning, as there is a growing recognition of the complexity of microbial ecosystems. - Basic Pathogen Characterization:
The focus on basic characterization of pathogens, such as morphology and biochemical properties, is decreasing in favor of more integrative approaches that include genomic and proteomic analyses.
Similar Journals
Jundishapur Journal of Microbiology
Bridging theory and practice in the realm of microbiology.Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.
Emerging Microbes & Infections
Elevating global health through open access research.Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.
TRENDS IN MICROBIOLOGY
Leading the Charge in High-Impact Microbial ResearchTRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.
JOURNAL OF INFECTION
Pioneering Insights into Infectious ProcessesJOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.
mSphere
Empowering breakthroughs in the world of microorganisms.mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.
Future Microbiology
Exploring Tomorrow's Microbiology TodayFuture Microbiology is a leading journal in the field of microbiology, published by FUTURE MEDICINE LTD in the United Kingdom. Since its inception in 2006, it has aimed to provide a comprehensive forum for the advancement of knowledge in microbiological research, particularly within the medical domain. With its current impact factor classifications placing it in Q3 for general microbiology and Q2 for medical microbiology as of 2023, it has established itself as a significant contributor to scientific discourse. The journal, featuring ISSN 1746-0913 and E-ISSN 1746-0921, actively engages researchers, professionals, and students, presenting them with novel insights and findings that enhance our understanding of microbial science. The publication is designed not only to showcase innovative research but also to foster collaborations and discussions across disciplines. While currently not offering open access, Future Microbiology remains committed to disseminating high-quality content that informs and inspires the ongoing exploration of microbiology and its critical role in healthcare.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Exploring the Complexities of Microbial PathogenesisWelcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
Advancing the Frontiers of Microbial and Molecular ScienceMICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, published by the American Society for Microbiology, is a premier journal dedicated to advancing the fields of microbiology and molecular biology. With an impressive impact factor reflective of its Q1 ranking in categories such as Immunology, Infectious Diseases, and Molecular Biology, this journal consistently showcases high-quality, peer-reviewed articles that contribute to the current understanding of microbial life and molecular mechanisms. Operating since 1997, the journal aims to bridge the gap between microbiological methods and molecular biology applications, making it an essential resource for researchers, professionals, and students alike. Readers can access content through various platforms, ensuring that the latest findings are readily available to the scientific community. With its esteemed reputation, MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS remains a leading voice in the exploration of the life sciences, catering to a broad audience deeply invested in unraveling the complexities of microbial and molecular systems.
Frontiers in Cellular and Infection Microbiology
Pioneering research for a healthier tomorrow.Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.
Pathogens
Empowering Knowledge in Immunology and MicrobiologyPathogens is a leading open-access journal published by MDPI since 2012, dedicated to advancing the understanding of infectious agents and their interactions with hosts in the fields of immunology, microbiology, and molecular biology. Based in Switzerland, this journal plays a crucial role in disseminating high-quality research that spans from fundamental studies of pathogen biology to the implications for global health and disease management. With a commendable impact factor and prestigious Q2 rankings across multiple categories—including Immunology and Microbiology—Pathogens ensures visibility and accessibility for groundbreaking findings. The journal embraces the ethos of open access, allowing researchers, professionals, and students to access critical research anytime, facilitating a collaborative and innovative academic environment. By bridging the gap between research and application, Pathogens is instrumental in shaping the future of infectious disease research and management.